{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:55:41Z","timestamp":1790873741435,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,3,3]],"date-time":"2006-03-03T00:00:00Z","timestamp":1141344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,3,21]]},"DOI":"10.1007\/s00213-005-0248-4","type":"journal-article","created":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T10:09:52Z","timestamp":1141294192000},"page":"265-273","source":"Crossref","is-referenced-by-count":112,"title":["Clozapine-induced sialorrhea: pathophysiology and management strategies"],"prefix":"10.1007","volume":"185","author":[{"given":"Samir Kumar","family":"Praharaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Gandotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,3]]},"reference":[{"issue":"1\u20132","key":"248_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/00016488309130932","volume":"95","author":"BH Ahlner","year":"1983","unstructured":"Ahlner BH, Lind MG (1983) A swab technique for sialometry. Normal range. Acta Otolaryngol 95(1\u20132):173\u2013182","journal-title":"Acta Otolaryngol"},{"key":"248_CR2","first-page":"250","volume":"24","author":"C Antonello","year":"1999","unstructured":"Antonello C, Tessier P (1999) Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect. J Psychiatry Neurosci 24:250","journal-title":"J Psychiatry Neurosci"},{"issue":"6","key":"248_CR3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00004714-200112000-00012","volume":"21","author":"YM Bai","year":"2001","unstructured":"Bai YM, Lin CC, Chen JY, Liu WC (2001) Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Psychopharmacol 21(6):608\u2013611","journal-title":"J Clin Psychopharmacol"},{"key":"248_CR4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000296852","volume":"160","author":"RJ Baldessarini","year":"1992","unstructured":"Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM (1992) Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry 160:12\u201316","journal-title":"Br J Psychiatry"},{"key":"248_CR5","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/0006-3223(95)00296-0","volume":"39","author":"H Ben-Areyh","year":"1996","unstructured":"Ben-Areyh H, Jungeman T, Szargel R, Klein E, Laufer D (1996) Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol Psychiatry 39:946\u2013949","journal-title":"Biol Psychiatry"},{"key":"248_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0165-6147(92)90085-K","volume":"13","author":"M Berlan","year":"1992","unstructured":"Berlan M, Montrstruc J, Lafontan M (1992) Pharmacological prospects for alpha 2 adrenoceptor antagonist therapy. Trends Pharmacol Sci 13:277\u2013282","journal-title":"Trends Pharmacol Sci"},{"key":"248_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0887-8994(02)00381-8","volume":"27","author":"JE Bothwell","year":"2002","unstructured":"Bothwell JE, Clarke K, Dooley JM et al (2002) Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol 27:18\u201322","journal-title":"Pediatr Neurol"},{"issue":"11","key":"248_CR8","first-page":"1174","volume":"42","author":"JA Bourgeois","year":"1991","unstructured":"Bourgeois JA, Drexler KG, Hall MJ (1991) Hypersalivation and clozapine. Hosp Community Psychiatry 42(11):1174","journal-title":"Hosp Community Psychiatry"},{"issue":"2","key":"248_CR9","first-page":"89","volume":"39","author":"HW Boyce","year":"2005","unstructured":"Boyce HW, Bakheet MR (2005) Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol 39(2):89\u201397","journal-title":"J Clin Gastroenterol"},{"key":"248_CR10","first-page":"445","volume":"153","author":"ES Brodkin","year":"1996","unstructured":"Brodkin ES, Pelton GH, Price LH (1996) Treatment of clozapine-induced parotid gland swelling. Am J Psychiatry 153:445","journal-title":"Am J Psychiatry"},{"key":"248_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200015010-00008","volume":"15","author":"J Calderon","year":"2000","unstructured":"Calderon J, Robin E, Sobota WL (2000) Potential use of ipratropium bromide for the treatment of clozapine induced hypersalivation: a preliminary report. Int Clin Psychopharmacol 15:49\u201352","journal-title":"Int Clin Psychopharmacol"},{"key":"248_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0039-6109(05)70405-9","volume":"80","author":"GW Carlson","year":"2000","unstructured":"Carlson GW (2000) The salivary glands. Embryology, anatomy, and surgical applications. Surg Clin North Am 80:261\u2013273","journal-title":"Surg Clin North Am"},{"key":"248_CR13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2125.1989.tb05440.x","volume":"28","author":"E Chatelut","year":"1989","unstructured":"Chatelut E, Rispail Y, Berlan M et al (1989) Yohimbine increases human salivary secretion. Br J Clin Pharmacol 28:366\u2013368","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"248_CR14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/000486700285","volume":"34","author":"C Comley","year":"2000","unstructured":"Comley C, Galletly C, Ash D (2000) Use of atropine eye drops for clozapine induced hypersalivation. Aust N Z J Psychiatry 34(6):1033\u20131034","journal-title":"Aust N Z J Psychiatry"},{"key":"248_CR15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1192\/bjp.159.1.166a","volume":"159","author":"PJ Copp","year":"1991","unstructured":"Copp PJ, Lament R, Tennent TG (1991) Amitriptyline in clozapine-induced sialorrhea. Br J Psychiatry 159:166","journal-title":"Br J Psychiatry"},{"key":"248_CR16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1192\/bjp.167.3.412a","volume":"167","author":"FM Corrigan","year":"1995","unstructured":"Corrigan FM, MacDonald S (1995) Clozapine-induced hypersalivation and the alpha 2 adrenoceptor. Br J Psychiatry 167:412","journal-title":"Br J Psychiatry"},{"key":"248_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1192\/pb.25.3.114","volume":"25","author":"A Cree","year":"2001","unstructured":"Cree A, Mir S, Fahy T (2001) A review of the treatment options for clozapine-induced hypersalivation. Psychiatr Bull 25:114\u2013116","journal-title":"Psychiatr Bull"},{"key":"248_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2005-837771","volume":"38","author":"B Croissant","year":"2005","unstructured":"Croissant B, Hermann D, Olbrich R (2005) Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation. Pharmacopsychiatry 38:38\u201339","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"248_CR19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1345\/aph.19259","volume":"34","author":"L Davydov","year":"2000","unstructured":"Davydov L, Botts SR (2000) Clozapine-induced hypersalivation. Ann Pharmacother 34(5):662\u2013665","journal-title":"Ann Pharmacother"},{"key":"248_CR20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0024-3205(93)90312-Q","volume":"52","author":"B Disse","year":"1993","unstructured":"Disse B, Reichl R, Speck G et al (1993) Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci 52:537\u2013544","journal-title":"Life Sci"},{"key":"248_CR21","unstructured":"Frankenburg AE (1991) Clozapine update. Tufts University School of Medicine, Ninth Annual Psychopharmacology Update, Boston"},{"issue":"1","key":"248_CR22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.jcp.0000106228.36344.2e","volume":"24","author":"O Freudenreich","year":"2004","unstructured":"Freudenreich O, Beebe M, Goff DC (2004) Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series. J Clin Psychopharmacol 24(1):98\u2013100","journal-title":"J Clin Psychopharmacol"},{"key":"248_CR23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(95)91713-6","volume":"346","author":"J Fritze","year":"1995","unstructured":"Fritze J, Elliger T (1995) Pirenzepine for clozapine-induced hypersalivation. Lancet 346:1034","journal-title":"Lancet"},{"issue":"3","key":"248_CR24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/appi.ps.55.3.318","volume":"55","author":"O Gaftanyuk","year":"2004","unstructured":"Gaftanyuk O, Trestman RL (2004) Scolpolamine patch for clozapine-induced sialorrhea. Psychiatr Serv 55(3):318","journal-title":"Psychiatr Serv"},{"issue":"1","key":"248_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004714-199202000-00026","volume":"12","author":"J Grabowski","year":"1992","unstructured":"Grabowski J (1992) Clonidine treatment of clozapine-induced hypersalivation. J Clin Psychopharmacol 12(1):69\u201370","journal-title":"J Clin Psychopharmacol"},{"key":"248_CR26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM198808253190806","volume":"319","author":"NJ Gross","year":"1988","unstructured":"Gross NJ (1988) Ipratropium bromide. N Engl J Med 319:486\u2013494","journal-title":"N Engl J Med"},{"key":"248_CR27","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.126.6.1946","volume":"126","author":"NJ Gross","year":"2004","unstructured":"Gross NJ (2004) Tiotropium bromide. Chest 126:1946\u20131953","journal-title":"Chest"},{"issue":"3","key":"248_CR28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1469-8749.1980.tb03708.x","volume":"22","author":"MM Harris","year":"1980","unstructured":"Harris MM, Dignam PF (1980) A nonsurgical method of reducing drooling in cerebral-palsied children. Dev Med Child Neurol 22(3):293\u2013299","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"248_CR29","first-page":"390","volume":"169","author":"R Hinkes","year":"1996","unstructured":"Hinkes R, Quesada TV, Currier MB, Gonzalez-Blanco M (1996) Aspiration pneumonia secondary to clozapine-induced sialorrhea. Br J Psychiatry 169(3):390\u2013391","journal-title":"Br J Psychiatry"},{"issue":"6","key":"248_CR30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mds.10276","volume":"17","author":"HC Hyson","year":"2002","unstructured":"Hyson HC, Johnson AM, Jog MS (2002) Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 17(6):1318\u20131320","journal-title":"Mov Disord"},{"key":"248_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","volume":"26","author":"J Ichikawa","year":"2002","unstructured":"Ichikawa J, Dai J, O\u2019Laughlin IA et al (2002) Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26:325\u2013339","journal-title":"Neuropsychopharmacology"},{"key":"248_CR32","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00005537-200410000-00023","volume":"114","author":"PH Jongerius","year":"2004","unstructured":"Jongerius PH, van Limbeek J, Rotteveel JJ (2004) Assessment of salivary flow rate: biologic variation and measure error. Laryngoscope 114:1801\u20131804","journal-title":"Laryngoscope"},{"issue":"1\u20132","key":"248_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-004-1803-0","volume":"173","author":"KG Kahl","year":"2004","unstructured":"Kahl KG, Hagenah J, Zapf S, Trillenberg P, Klein C, Lencer R (2004) Botulinum toxin as an effective treatment of clozapine-induced hypersalivation. Psychopharmacology (Berl) 173(1\u20132):229\u2013230","journal-title":"Psychopharmacology (Berl)"},{"key":"248_CR34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine. Arch Gen Psychiatry 45:789\u2013796","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"248_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01064682","volume":"63","author":"JA Lieberman","year":"1992","unstructured":"Lieberman JA, Safferman AZ (1992) Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatr Q 63(1):51\u201370","journal-title":"Psychiatr Q"},{"issue":"9","key":"248_CR36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","volume":"61","author":"A Lipp","year":"2003","unstructured":"Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G (2003) A randomized trial of botulinum toxin A for treatment of drooling. Neurology 61(9):1279\u20131281","journal-title":"Neurology"},{"issue":"6","key":"248_CR37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","volume":"18","author":"F Mancini","year":"2003","unstructured":"Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G et al (2003) Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 18(6):685\u2013688","journal-title":"Mov Disord"},{"key":"248_CR38","doi-asserted-by":"crossref","first-page":"B27","DOI":"10.1177\/00220345750540022001","volume":"54","author":"ID Mandel","year":"1975","unstructured":"Mandel ID, Zengo A, Katz R, Wotman S (1975) Effect of adrenergic agents on salivary composition. J Dent Res 54:B27\u2013B33","journal-title":"J Dent Res"},{"key":"248_CR39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0278-5846(94)90010-8","volume":"18","author":"D Marinkovic","year":"1994","unstructured":"Marinkovic D, Timotijevic I, Babinski T et al (1994) The side effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 18:537\u2013544","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"248_CR40","first-page":"281","volume":"14","author":"R McCarthy","year":"1994","unstructured":"McCarthy R, Terkelsen K (1994) Oesophageal dysfunction in two patients after clozapine treatment. J Clin Psychopharmacol 14:281\u2013283","journal-title":"J Clin Psychopharmacol"},{"key":"248_CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1192\/pb.25.7.277-c","volume":"25","author":"JP McKane","year":"2001","unstructured":"McKane JP, Hall C, Akram G (2001) Hyoscine patches in clozapine induced hypersalivation. Psychiatr Bull 25:277","journal-title":"Psychiatr Bull"},{"issue":"1\u20132","key":"248_CR42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(99)00341-6","volume":"376","author":"P Michal","year":"1999","unstructured":"Michal P, Lysikova M, El-Fakahany EE, Tucek S (1999) Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors. Eur J Pharmacol 376(1\u20132):119\u2013125","journal-title":"Eur J Pharmacol"},{"key":"248_CR43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","volume":"154","author":"RJ Mier","year":"2000","unstructured":"Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M (2000) Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 154:1214\u20131218","journal-title":"Arch Pediatr Adolesc Med"},{"key":"248_CR44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/00220345820610100901","volume":"61","author":"M Navazesh","year":"1982","unstructured":"Navazesh M, Christensen CM (1982) A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 61:1158\u20131162","journal-title":"J Dent Res"},{"key":"248_CR45","first-page":"2718","volume-title":"Kaplan & Sadock\u2019s comprehensive textbook of psychiatry, vol. 2","author":"CB Nemeroff","year":"2005","unstructured":"Nemeroff CB, Putnam JS (2005) \u03b12-Adrenergic receptor agonists: clonidine and guanfacine. In: Sadock BJ, Sadock VA (eds) Kaplan & Sadock\u2019s comprehensive textbook of psychiatry, vol. 2. Lippincot Williams & Wilkins, Philadelphia, pp 2718\u20132722"},{"issue":"suppl","key":"248_CR46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0022-510X(96)00104-9","volume":"139","author":"AR Newall","year":"1996","unstructured":"Newall AR, Orser R, Hunt M (1996) The control of oral secretions in bulbar ALS\/MND. J Neurol Sci 139(suppl):43\u201344","journal-title":"J Neurol Sci"},{"key":"248_CR47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000118354","volume":"17","author":"C Ogura","year":"1987","unstructured":"Ogura C, Kishimoto A, Mizukawa R (1987) Comparative study of the effects of 9 antidepressants on several physiological parameters in healthy volunteers. Neuropsychobiology 17:139\u2013144","journal-title":"Neuropsychobiology"},{"issue":"4","key":"248_CR48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004714-199408000-00013","volume":"14","author":"C Pearlman","year":"1994","unstructured":"Pearlman C (1994) Clozapine, nocturnal sialorrhea, and choking. J Clin Psychopharmacol 14(4):283","journal-title":"J Clin Psychopharmacol"},{"key":"248_CR49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0016-5085(19)33524-3","volume":"61","author":"JL Pitcher","year":"1971","unstructured":"Pitcher JL (1971) Safety and effectiveness of the modified Sengstaken\u2013Blakemore tube: a prospective study. Gastroenterology 61:291\u2013298","journal-title":"Gastroenterology"},{"issue":"4","key":"248_CR50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0269881105053311","volume":"19","author":"SK Praharaj","year":"2005","unstructured":"Praharaj SK, Verma P, Roy D, Singh A (2005) Is clonidine useful for treatment of clozapine-induced sialorrhea? J Psychopharmacol 19(4):426\u2013428","journal-title":"J Psychopharmacol"},{"key":"248_CR51","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0006-3223(96)89255-9","volume":"40","author":"T Rabinowitz","year":"1996","unstructured":"Rabinowitz T, Frankenburg FR, Centorrino F, Kando J (1996) The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry 40:1132\u20131134","journal-title":"Biol Psychiatry"},{"key":"248_CR52","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1469-8749.1980.tb04349.x","volume":"22","author":"D Rapp","year":"1980","unstructured":"Rapp D (1980) Drool control: long-term follow-up. Dev Med Child Neurol 22:448\u2013453","journal-title":"Dev Med Child Neurol"},{"key":"248_CR53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1440-1754.1992.tb02699.x","volume":"28","author":"D Reddihough","year":"1992","unstructured":"Reddihough D, Johnson H, Ferguson E (1992) The role of a saliva control clinic in the management of drooling. J Paediatr Child Health 28:395\u2013397","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"248_CR54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00044011-199917020-00003","volume":"17","author":"MJ Reinstein","year":"1999","unstructured":"Reinstein MJ, Sirotovskaya LA, Chasanov MA, Jones LE (1999) Comparative efficacy and tolerability of benztropine and terazosin in the treatment of hypersalivation secondary to clozapine. Clin Drug Investig 17(2):97\u2013102","journal-title":"Clin Drug Investig"},{"key":"248_CR55","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.158.8.1329-a","volume":"158","author":"C Richardson","year":"2001","unstructured":"Richardson C, Kelly DL, Conley RR (2001) Biperiden for excessive sweating from clozapine. Am J Psychiatry 158:1329\u20131330","journal-title":"Am J Psychiatry"},{"key":"248_CR56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-2999(84)90478-3","volume":"103","author":"E Richelson","year":"1984","unstructured":"Richelson E, Nelson A (1984) Antagonism by neuroleptics of neurotransmitter of normal brain in vitro. Eur J Pharmacol 103:197\u2013204","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"248_CR57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/ajp.152.2.297","volume":"152","author":"D Robinson","year":"1995","unstructured":"Robinson D, Fenn H, Yesavage J (1995) Possible association of parotitis with clozapine. Am J Psychiatry 152(2):297\u2013298","journal-title":"Am J Psychiatry"},{"issue":"9","key":"248_CR58","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1592\/phco.20.13.1092.35036","volume":"20","author":"D Rogers","year":"2000","unstructured":"Rogers D, Shramko J (2000) Therapeutic options in the treatment of clozapine-induced sialorrhoea. Pharmacotherapy 20(9):1092\u20131095","journal-title":"Pharmacotherapy"},{"issue":"6","key":"248_CR59","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ijporl.2004.01.005","volume":"68","author":"LJC Rotteveel","year":"2004","unstructured":"Rotteveel LJC, Jongerius PH, van Limbeek J, van den Hoogen FJA (2004) Salivation in healthy school children. Int J Pediatr Otorhinolaryngol 68(6):767\u2013774","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"248_CR60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/schbul\/17.2.247","volume":"17","author":"A Safferman","year":"1991","unstructured":"Safferman A, Liberman J, Kane M et al (1991) Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 17:247\u2013261","journal-title":"Schizophr Bull"},{"issue":"1","key":"248_CR61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0773.1994.tb01070.x","volume":"74","author":"C Sanchez","year":"1994","unstructured":"Sanchez C, Lembol HL (1994) The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice. Pharmacol Toxicol 74(1):35\u201339","journal-title":"Pharmacol Toxicol"},{"issue":"2","key":"248_CR62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2004-815523","volume":"37","author":"B Schneider","year":"2004","unstructured":"Schneider B, Weigmann H, Hiemke C, Weber B, Fritze J (2004) Reduction of clozapine-induced hypersalivation by pirenzepine is safe. Pharmacopsychiatry 37(2):43\u201345","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"248_CR63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1469-8749.2004.tb00444.x","volume":"46","author":"JE Senner","year":"2004","unstructured":"Senner JE, Logemann J, Zecker S, Gaebler-Spira D (2004) Drooling, saliva production, and swallowing in cerebral palsy. Dev Med Child Neurol 46(12):801\u2013806","journal-title":"Dev Med Child Neurol"},{"key":"248_CR64","first-page":"605","volume":"63","author":"AE Sochaniwskyj","year":"1982","unstructured":"Sochaniwskyj AE (1982) Drool quantification: noninvasive technique. Arch Phys Med Rehabil 63:605\u2013607","journal-title":"Arch Phys Med Rehabil"},{"key":"248_CR65","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00004714-199612000-00013","volume":"16","author":"B Spivak","year":"1996","unstructured":"Spivak B, Adlersberg S, Rosen L, Gonen N, Mester R, Weizman A (1996) Trihexyphenidyl treatment of clozapine-induced hypersalivation. J Clin Psychopharmacol 16:462\u2013463","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"248_CR66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004850-199707000-00005","volume":"12","author":"B Spivak","year":"1997","unstructured":"Spivak B, Adlersberg S, Rosen L, Gonen N, Mester R, Weizman A (1997) Trihexyphenidyl treatment of clozapine-induced hypersalivation. Int Clin Psychopharmacol 12(4):213\u2013215","journal-title":"Int Clin Psychopharmacol"},{"key":"248_CR67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005537-200201000-00014","volume":"112","author":"DL Suskind","year":"2002","unstructured":"Suskind DL, Tilton A (2002) Clinical study of Botulinum-A toxin in the treatment of sialorrhea with children with cerebral palsy. Laryngoscope 112:73\u201381","journal-title":"Laryngoscope"},{"issue":"3","key":"248_CR68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1192\/bjp.169.3.380b","volume":"169","author":"E Szabadi","year":"1996","unstructured":"Szabadi E (1996) Clozapine-induced hypersalivation and the alpha-2 adrenoceptor. Br J Psychiatry 169(3):380\u2013381","journal-title":"Br J Psychiatry"},{"key":"248_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(01)00170-X","volume":"93","author":"B Szabo","year":"2002","unstructured":"Szabo B (2002) Imidazoline antihypertensive drugs: critical review on their mechanism of action. Pharmacol Ther 93:1\u201335","journal-title":"Pharmacol Ther"},{"key":"248_CR70","doi-asserted-by":"crossref","DOI":"10.3109\/9780203414125","volume-title":"The South London and Maudsley NHS Trust 2003 prescribing guidelines","author":"D Taylor","year":"2003","unstructured":"Taylor D, Paton C, Kerwin R (2003) The South London and Maudsley NHS Trust 2003 prescribing guidelines. Martin Dunitz, London"},{"key":"248_CR71","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0006-3223(96)89255-9","volume":"40","author":"R Terry","year":"1996","unstructured":"Terry R, Frances RF, Franca C, Judith K (1996) The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry 40:1132\u20131134","journal-title":"Biol Psychiatry"},{"issue":"3","key":"248_CR72","first-page":"253","volume":"26","author":"P Tessier","year":"2001","unstructured":"Tessier P, Antonello C (2001) Clozapine and sialorrhea: update. J Psychiatry Neurosci 26(3):253","journal-title":"J Psychiatry Neurosci"},{"key":"248_CR73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","volume":"3","author":"N Thomas-Stonell","year":"1988","unstructured":"Thomas-Stonell N, Greenberg J (1988) Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 3:73\u201378","journal-title":"Dysphagia"},{"key":"248_CR74","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1213\/00000539-198612000-00006","volume":"65","author":"JR Thorburn","year":"1986","unstructured":"Thorburn JR, James MF, Feldman C, Moyes DG, Du Toit PS (1986) Comparison of the effects of atropine and glycopyrrolate on pulmonary mechanics in patients undergoing fibreoptic bronchoscopy. Anesth Analg 65:1285\u20131289","journal-title":"Anesth Analg"},{"issue":"11","key":"248_CR75","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1345\/aph.1C019","volume":"36","author":"DZ Tscheng","year":"2002","unstructured":"Tscheng DZ (2002) Sialorrhea\u2014therapeutic drug options. Ann Pharmacother 36(11):1785\u20131790","journal-title":"Ann Pharmacother"},{"key":"248_CR76","first-page":"2914","volume-title":"Kaplan & Sadock\u2019s comprehensive textbook of psychiatry, vol. 2","author":"DP Kammen Van","year":"2005","unstructured":"Van Kammen DP, Marder SR (2005) Serotonin\u2013dopamine antagonists (atypical or second generation antipsychotics). In: Sadock BJ, Sadock VA (eds) Kaplan & Sadock\u2019s comprehensive textbook of psychiatry, vol. 2. Lippincot Williams & Wilkins, Philadelphia, pp 2914\u20132938"},{"issue":"11","key":"248_CR77","first-page":"511","volume":"56","author":"JS Vasile","year":"1995","unstructured":"Vasile JS, Steingard S (1995) Clozapine and the development of salivary gland swelling: a case study. J Clin Psychiatry 56(11):511\u2013513","journal-title":"J Clin Psychiatry"},{"key":"248_CR79","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00023210-199504050-00006","volume":"1","author":"AJ Wagstaff","year":"1995","unstructured":"Wagstaff AJ, Bryson HM (1995) Clozapine: a review of its pharmacological properties and a therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents. CNS Drugs 1:370\u2013400","journal-title":"CNS Drugs"},{"issue":"4","key":"248_CR78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00023210-200317040-00004","volume":"17","author":"A Wagstaff","year":"2003","unstructured":"Wagstaff A, Perry C (2003) Clozapine: in prevention of suicide in patients with schizophrenia or schizo-affective disorder. CNS Drugs 17(4):273\u2013280 (discussion 281\u2013283)","journal-title":"CNS Drugs"},{"issue":"6","key":"248_CR80","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.jcp.0000145348.06783.1d","volume":"24","author":"MA Webber","year":"2004","unstructured":"Webber MA, Szwast SJ, Steadman TM, Frazer A, Malloy FW, Lightfoot JD et al (2004) Guanfacine treatment of clozapine-induced sialorrhea. J Clin Psychopharmacol 24(6):675\u2013676","journal-title":"J Clin Psychopharmacol"},{"key":"248_CR81","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.schbul.a033333","volume":"24","author":"CR Young","year":"1998","unstructured":"Young CR, Bowers MB, Mazure CM (1998) Management of the adverse effects of clozapine. Schizophr Bull 24:381\u2013390","journal-title":"Schizophr Bull"},{"issue":"4","key":"248_CR82","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0885-3924(98)00143-2","volume":"17","author":"G Zeppetella","year":"1999","unstructured":"Zeppetella G (1999) Nebulized scopolamine in the management of oral dribbling: three case reports. J Pain Symptom Manage 17(4):293\u2013295","journal-title":"J Pain Symptom Manage"},{"key":"248_CR83","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0922-4106(94)90047-7","volume":"269","author":"SH Zorn","year":"1994","unstructured":"Zorn SH, Jones SB, Ward KM, Liston DR (1994) Clozapine is a potent and selective muscarinic M4 receptor agonist. Eur J Pharmacol 269:R1\u2013R2","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-0248-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0248-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:26:10Z","timestamp":1586737570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-0248-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3,21]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-0248-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,3]]}}}